Subscribe to Press Releases


Immunotherapies for Life

Expanded Access

Expanded access is for patients with a serious or life-threatening disease or condition to receive treatment with an investigational medical product outside of clinical trials when there are no comparable or satisfactory therapies available.

Investigational medical products are investigational drugs that have not been approved by FDA or other regulatory authorities. In the situation where patients have no further medical options Y-mAbs Therapeutics, Inc. may consider requests from physicians to make an investigational drug available to their patients on an “expanded access” basis. As these requests are complex Y-mAbs Therapeutics, Inc has gathered relevant information for expanded access and established a policy to govern request from physicians for expanded access of investigational products for individual patients.

Expanded Access